GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...

A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...

A new cancer vaccine is being developed which scientists hope could target the disease before it takes hold. The University ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...